Hyperfine (HYPR) EPS (Basic) Growth (1y) (2022 - 2026)
Hyperfine (HYPR) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 114.97% |
| 10 | Hyperfine | 92.34 Mn | 51.06 Mn | 1.98 Mn | 29.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.06% |
| Dec 31, 2025 | 49.63% |
| Sep 30, 2025 | 1.86% |
| Jun 30, 2025 | 16.19% |
| Mar 31, 2025 | 9.12% |
| Dec 31, 2024 | 4.23% |
| Sep 30, 2024 | 5.61% |
| Jun 30, 2024 | 5.64% |
| Mar 31, 2024 | 20.22% |
| Dec 31, 2023 | 19.18% |
| Sep 30, 2023 | 19.42% |
| Jun 30, 2023 | 54.62% |
| Mar 31, 2023 | 49.24% |
| Dec 31, 2022 | 97.38% |
| Sep 30, 2022 | 97.84% |
| Jun 30, 2022 | 96.26% |
| Mar 31, 2022 | 93.05% |